Irish Life Investment Managers’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Irish Life Investment Managers’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$29.1K	Buy	+1,938	New	+$25.6K	﹤0.01%	1756

Other funds holding MNTA

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Irish Life Investment Managers's MNTA Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2013: 1,938 shares worth $29.1K. The stake represents ﹤0.01% of the portfolio and ranks #1756 among its holdings.

111 funds tracked by Wall St. Rank hold MNTA as of Q2 2013.

Irish Life Investment Managers held 1,938 shares of Momenta Pharmaceuticals, Inc. worth $29.1K as of Q2 2013.
Momenta Pharmaceuticals, Inc. was a new Irish Life Investment Managers position in Q2 2013.
Momenta Pharmaceuticals, Inc. made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1756 holding.
111 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.